KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Intangibles (2016 - 2025)

Bausch Health Companies' Intangibles history spans 10 years, with the latest figure at $6.5 billion for Q4 2023.

  • For Q4 2023, Intangibles rose 11.31% year-over-year to $6.5 billion; the TTM value through Dec 2023 reached $6.5 billion, up 11.31%, while the annual FY2023 figure was $6.5 billion, 11.31% up from the prior year.
  • Intangibles for Q4 2023 was $6.5 billion at Bausch Health Companies, up from $5.8 billion in the prior quarter.
  • Across five years, Intangibles topped out at $8.4 billion in Q4 2020 and bottomed at $5.8 billion in Q4 2022.
  • The 4-year median for Intangibles is $6.5 billion (2023), against an average of $6.8 billion.
  • The largest annual shift saw Intangibles decreased 17.73% in 2021 before it increased 11.31% in 2023.
  • A 4-year view of Intangibles shows it stood at $8.4 billion in 2020, then fell by 17.73% to $6.9 billion in 2021, then fell by 16.52% to $5.8 billion in 2022, then rose by 11.31% to $6.5 billion in 2023.
  • Per Business Quant, the three most recent readings for BHC's Intangibles are $6.5 billion (Q4 2023), $5.8 billion (Q4 2022), and $6.3 billion (Q2 2022).